-
1
-
-
0029838112
-
Targeted T-cell therapy for human leukemia: Cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells
-
Molldrem J, Dermime S, Parker K, et al. Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood. 1996;88:2450-2457.
-
(1996)
Blood
, vol.88
, pp. 2450-2457
-
-
Molldrem, J.1
Dermime, S.2
Parker, K.3
-
2
-
-
0030841573
-
Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units
-
Molldrem JJ, Clave E, Jiang YZ, et al. Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units. Blood. 1997;90:2529-2534.
-
(1997)
Blood
, vol.90
, pp. 2529-2534
-
-
Molldrem, J.J.1
Clave, E.2
Jiang, Y.Z.3
-
3
-
-
0033826799
-
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
-
Molldrem JJ, Lee PP, Wang C, et al. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med. 2000;6:1018-1023.
-
(2000)
Nat Med
, vol.6
, pp. 1018-1023
-
-
Molldrem, J.J.1
Lee, P.P.2
Wang, C.3
-
4
-
-
0141889279
-
Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation
-
Rezvani K, Grube M, Brenchley JM, et al. Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation. Blood. 2003;102:2892-2900.
-
(2003)
Blood
, vol.102
, pp. 2892-2900
-
-
Rezvani, K.1
Grube, M.2
Brenchley, J.M.3
-
5
-
-
0037105370
-
CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia
-
Scheibenbogen C, Letsch A, Thiel E, et al. CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia. Blood. 2002;100:2132-2137.
-
(2002)
Blood
, vol.100
, pp. 2132-2137
-
-
Scheibenbogen, C.1
Letsch, A.2
Thiel, E.3
-
6
-
-
34248148589
-
Transfer of PR1-specific T-cell clones from donor to recipient by stem cell transplantation and association with GvL activity
-
Rezvani K, Price D, Brenchley J, et al. Transfer of PR1-specific T-cell clones from donor to recipient by stem cell transplantation and association with GvL activity. Cytotherapy. 2007;9:245-251.
-
(2007)
Cytotherapy
, vol.9
, pp. 245-251
-
-
Rezvani, K.1
Price, D.2
Brenchley, J.3
-
7
-
-
38049112538
-
-
Qazilbash MH, Wieder E, Rios R, et al. Vaccination with the PR1 leukemia-associated antigen can induce complete remission in patients with myeloid leukemia [abstract]. ASH Annual Meeting Abstracts. 2004;104:259.
-
Qazilbash MH, Wieder E, Rios R, et al. Vaccination with the PR1 leukemia-associated antigen can induce complete remission in patients with myeloid leukemia [abstract]. ASH Annual Meeting Abstracts. 2004;104:259.
-
-
-
-
8
-
-
0030737629
-
High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome
-
Bergmann L, Miething C, Maurer U, et al. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood. 1997;90:1217-1225.
-
(1997)
Blood
, vol.90
, pp. 1217-1225
-
-
Bergmann, L.1
Miething, C.2
Maurer, U.3
-
9
-
-
0029069227
-
Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias
-
Menssen HD, Renkl HJ, Rodeck U, et al. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia. 1995;9:1060-1067.
-
(1995)
Leukemia
, vol.9
, pp. 1060-1067
-
-
Menssen, H.D.1
Renkl, H.J.2
Rodeck, U.3
-
10
-
-
0032837114
-
wt1 gene expression in childhood leukemias
-
Niegemann E, Wehner S, Kornhuber B, Schwabe D, Ebener U. wt1 gene expression in childhood leukemias. Acta Haematol. 1999;102:72-76.
-
(1999)
Acta Haematol
, vol.102
, pp. 72-76
-
-
Niegemann, E.1
Wehner, S.2
Kornhuber, B.3
Schwabe, D.4
Ebener, U.5
-
11
-
-
0036361833
-
Wilms tumor gene WT1 as a tumor marker for leukemic blast cells and its role in leukemogenesis
-
Sugiyama H. Wilms tumor gene WT1 as a tumor marker for leukemic blast cells and its role in leukemogenesis. Methods Mol Med. 2002;68:223-237.
-
(2002)
Methods Mol Med
, vol.68
, pp. 223-237
-
-
Sugiyama, H.1
-
12
-
-
0038011942
-
Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes
-
Cilloni D, Gottardi E, Messa F, et al. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes. J Clin Oncol. 2003;21:1988-1995.
-
(2003)
J Clin Oncol
, vol.21
, pp. 1988-1995
-
-
Cilloni, D.1
Gottardi, E.2
Messa, F.3
-
13
-
-
0028130136
-
WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia
-
Inoue K, Sugiyama H, Ogawa H, et al. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood. 1994;84:3071-3079.
-
(1994)
Blood
, vol.84
, pp. 3071-3079
-
-
Inoue, K.1
Sugiyama, H.2
Ogawa, H.3
-
14
-
-
0031048878
-
Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia
-
Inoue K, Ogawa H, Sonoda Y, et al. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood. 1997;89:1405-1412.
-
(1997)
Blood
, vol.89
, pp. 1405-1412
-
-
Inoue, K.1
Ogawa, H.2
Sonoda, Y.3
-
15
-
-
0037370833
-
The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia
-
Ogawa H, Tamaki H, Ikegame K, et al. The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. Blood. 2003;101:1698-1704.
-
(2003)
Blood
, vol.101
, pp. 1698-1704
-
-
Ogawa, H.1
Tamaki, H.2
Ikegame, K.3
-
16
-
-
0034176750
-
Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1
-
Gao L, Bellantuono I, Elsasser A, et al. Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood. 2000;95:2198-2203.
-
(2000)
Blood
, vol.95
, pp. 2198-2203
-
-
Gao, L.1
Bellantuono, I.2
Elsasser, A.3
-
17
-
-
0033966369
-
HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide
-
Ohminami H, Yasukawa M, Fujita S. HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide. Blood. 2000;95:286-293.
-
(2000)
Blood
, vol.95
, pp. 286-293
-
-
Ohminami, H.1
Yasukawa, M.2
Fujita, S.3
-
18
-
-
0034112824
-
Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product
-
Oka Y, Elisseeva OA, Tsuboi A, et al. Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product. Immunogenetics. 2000;51:99-107.
-
(2000)
Immunogenetics
, vol.51
, pp. 99-107
-
-
Oka, Y.1
Elisseeva, O.A.2
Tsuboi, A.3
-
19
-
-
20444378186
-
Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia: Implications for vaccine development and adoptive cellular immunotherapy
-
Gannage M, Abel M, Michallet AS, et al. Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia: implications for vaccine development and adoptive cellular immunotherapy. J Immunol. 2005;174:8210-8218.
-
(2005)
J Immunol
, vol.174
, pp. 8210-8218
-
-
Gannage, M.1
Abel, M.2
Michallet, A.S.3
-
20
-
-
31544461292
-
Detection of Wilms' tumor antigen-specific CTL in tumor-draining lymph nodes of patients with early breast cancer
-
Gillmore R, Xue SA, Holler A, et al. Detection of Wilms' tumor antigen-specific CTL in tumor-draining lymph nodes of patients with early breast cancer. Clin Cancer Res. 2006;12:34-42.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 34-42
-
-
Gillmore, R.1
Xue, S.A.2
Holler, A.3
-
21
-
-
29344436442
-
T-Cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: Identification, quantification, and characterization
-
Rezvani K, Brenchley JM, Price DA, et al. T-Cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterization. Clin Cancer Res. 2005;11:8799-8807.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 8799-8807
-
-
Rezvani, K.1
Brenchley, J.M.2
Price, D.A.3
-
22
-
-
34548857324
-
Graft-versus-leukemia effects associated with detectable Wilms tumor-1-specific T lymphocytes following allogeneic stem-cell transplantation for acute lymphoblastic leukemia (ALL)
-
Rezvani K, Yong ASM, Savani BN, et al. Graft-versus-leukemia effects associated with detectable Wilms tumor-1-specific T lymphocytes following allogeneic stem-cell transplantation for acute lymphoblastic leukemia (ALL). Blood. 2007;110:1924-1932.
-
(2007)
Blood
, vol.110
, pp. 1924-1932
-
-
Rezvani, K.1
Yong, A.S.M.2
Savani, B.N.3
-
23
-
-
0742324477
-
Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity
-
Mailander V, Scheibenbogen C, Thiel E, et al. Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity. Leukemia. 2004;18:165-166.
-
(2004)
Leukemia
, vol.18
, pp. 165-166
-
-
Mailander, V.1
Scheibenbogen, C.2
Thiel, E.3
-
24
-
-
0042347518
-
Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis
-
Oka Y, Tsuboi A, Murakami M, et al. Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis. Int J Hematol. 2003;78:56-61.
-
(2003)
Int J Hematol
, vol.78
, pp. 56-61
-
-
Oka, Y.1
Tsuboi, A.2
Murakami, M.3
-
25
-
-
4644289323
-
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
-
Oka Y, Tsuboi A, Taguchi T, et al. Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci U S A. 2004;101:13885-13890.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 13885-13890
-
-
Oka, Y.1
Tsuboi, A.2
Taguchi, T.3
-
26
-
-
9144271651
-
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR): A Europe against cancer program
-
Beillard E, Pallisgaard N, van der Velden VH, et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR): a Europe against cancer program. Leukemia. 2003;17:2474-2486.
-
(2003)
Leukemia
, vol.17
, pp. 2474-2486
-
-
Beillard, E.1
Pallisgaard, N.2
van der Velden, V.H.3
-
27
-
-
30144445384
-
Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML
-
Yong AS, Szydlo RM, Goldman JM, Apperley JF, Melo JV. Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML. Blood. 2006;107:205-212.
-
(2006)
Blood
, vol.107
, pp. 205-212
-
-
Yong, A.S.1
Szydlo, R.M.2
Goldman, J.M.3
Apperley, J.F.4
Melo, J.V.5
-
28
-
-
9144222001
-
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia: A Europe Against Cancer program
-
Gabert J, Beillard E, van der Velden VH, et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia: a Europe Against Cancer program. Leukemia. 2003;17:2318-2357.
-
(2003)
Leukemia
, vol.17
, pp. 2318-2357
-
-
Gabert, J.1
Beillard, E.2
van der Velden, V.H.3
-
29
-
-
0030691757
-
Phenotypic and functional separation of memory and effector human CD8 T cells
-
Hamann D, Baars PA, Rep MH, et al. Phenotypic and functional separation of memory and effector human CD8 T cells. J Exp Med. 1997;186:1407-1418.
-
(1997)
J Exp Med
, vol.186
, pp. 1407-1418
-
-
Hamann, D.1
Baars, P.A.2
Rep, M.H.3
-
30
-
-
0034329745
-
CD27 is required for generation and long-term maintenance of T cell immunity
-
Hendriks J, Gravestein LA, Tesselaar K, et al. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol. 2000;1:433-440.
-
(2000)
Nat Immunol
, vol.1
, pp. 433-440
-
-
Hendriks, J.1
Gravestein, L.A.2
Tesselaar, K.3
-
31
-
-
2942597447
-
WT1 gene expression: An excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients: results from a single-centre study
-
Ostergaard M, Olesen LH, Hasle H, Kjeldsen E, Hokland P. WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients: results from a single-centre study. Br J Haematol. 2004;125:590-600.
-
(2004)
Br J Haematol
, vol.125
, pp. 590-600
-
-
Ostergaard, M.1
Olesen, L.H.2
Hasle, H.3
Kjeldsen, E.4
Hokland, P.5
|